Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
137 USD | -0.83% | +0.13% | -0.11% |
04-30 | Baird Adjusts Quest Diagnostics' Price Target to $144 From $138 | MT |
04-29 | US FDA publishes final rule for laboratory developed tests | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.11% | 15.35B | |
-29.47% | 85.35B | |
+13.77% | 81.95B | |
+9.37% | 28.99B | |
-11.58% | 16.98B | |
-0.36% | 16.85B | |
+4.32% | 12.42B | |
+31.75% | 12.19B | |
-31.40% | 11.89B | |
-2.34% | 11.88B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- Credit Suisse Lowers Quest Diagnostics' Price Target to $143 from $158, Adjusts 2023 EV/EBITDA Multiple; Keeps Neutral Rating